Oxalys
ActiveSummary
Oxalys has been active since 1993 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €178,408 and a net result of -€12,503. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 79% of 2,423 sector peers (NACE 90, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
31-12
Gazette deed
Appointments: Sofie Bultinck (director) and Toon Fret (director)Resignations: Hubert De Neve (director) and Martijn Vink (director) · Registered-office move · Amendment of the articles23 facts ▸
- General meeting, 13-12-2023
- Registered-office move, Masuiplein 13, 1000 Brussel
- Director appointment, Sofie Bultinck (director)
- Director appointment, Toon Fret (director)
- Director resignation, Hubert De Neve (director)
- Other provision, “lid van de algemene Vergadering, lid van de algemene Vergadering” (deed in Dutch) (2 times)
- Director resignation, Martijn Vink (director)
- Board composition, Bert Anciaux (chair)
- Board composition, Liesbet Martens (secretary)
- Board composition, Piet Van Bockstal (director)
- Board composition, Bart Caron (director)
- Board composition, Shirly Laub (director)
- +11 further facts in this act
Show earlier events
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.